文献速递临床试验与 GCP流行病学与生物统计

地中海饮食或正念减压对高危孕妇小于胎龄儿出生体重的影响:IMPACT BCN随机临床试验

Effects of Mediterranean Diet or Mindfulness-Based Stress Reduction on Prevention of Small-for-Gestational Age Birth Weights in Newborns Born to At-Risk Pregnant Individuals: The IMPACT BCN Randomized Clinical Trial.
PubMed 文献 · JAMA · 2021-01-01

在西班牙巴塞罗那一所大学医院开展的平行组随机临床试验,纳入1221例孕19-23周、小于胎龄儿高风险的单身妊娠个体。与常规护理相比,地中海饮食组和正念减压组的新生儿小于胎龄儿百分比及复合不良围产结局均显著降低。因研究存在重要局限性,作者认为这些发现应视为初步结果,需重复验证并在其他人群评估后才能推荐用于患者。

要点

  • 地中海饮食组小于胎龄儿发生率为14.0%,低于对照组21.9%(OR 0.58,95%CI 0.40-0.84)。
  • 正念减压组小于胎龄儿发生率为15.6%,低于对照组21.9%(OR 0.66,95%CI 0.46-0.94)。
  • 地中海饮食组和正念减压组复合不良围产结局均低于对照组(18.6%和19.5% vs 26.2%)。

核心结论

  • 在高危孕妇中,与常规护理相比,结构化地中海饮食或正念减压干预显著降低了出生体重低于第10百分位的新生儿百分比。
  • 因存在重要研究局限性,这些发现应视为初步结果,需重复验证并在其他患者人群中评估后,才能推荐用于患者。

研究设计与样本

  • 平行组随机临床试验,在西班牙巴塞罗那一所大学医院开展。
  • 纳入1221例孕19-23周、小于胎龄儿高风险的单身妊娠个体,入组时间2017年2月1日至2019年10月10日,随访至分娩(末次随访2020年3月1日)。
  • 地中海饮食组407例、正念减压组407例、常规护理组407例;完成试验1184例(97%),分别为392例、391例和401例。

主要发现

  • 小于胎龄儿发生在对照组88例新生儿(21.9%)、地中海饮食组55例(14.0%)(OR 0.58,95%CI 0.40-0.84;RD -7.9,95%CI -13.6至-2.6;P=0.004)、正念减压组61例(15.6%)(OR 0.66,95%CI 0.46-0.94;RD -6.3,95%CI -11.8至-0.9;P=0.02)。
  • 复合不良围产结局发生在对照组105例新生儿(26.2%)、地中海饮食组73例(18.6%)(OR 0.64,95%CI 0.46-0.90;RD -7.6,95%CI -13.4至-1.8;P=0.01)、正念减压组76例(19.5%)(OR 0.68,95%CI 0.49-0.95;RD -6.8,95%CI -12.6至-0.3;P=0.02)。
  • 随机分组个体1221例,中位年龄37岁(IQR 34-40岁)。

关键数值与推荐

  • 主要终点为分娩时小于胎龄儿百分比,定义为出生体重低于第10百分位。
  • 次要终点为复合不良围产结局(早产、子痫前期、围产期死亡、重度小于胎龄儿、新生儿酸中毒、低Apgar评分或任何重大新生儿疾病中至少1项)。
  • 地中海饮食组接受每月2小时个体和小组教育课程,并免费提供特级初榨橄榄油和核桃。
  • 正念减压组接受为期8周、适应妊娠的减压方案,包括每周2.5小时课程和1个全天课程。
  • 常规护理组按机构方案接受妊娠护理。

临床怎么用

  • 原文结论指出,这些发现应视为初步结果,需重复验证并在其他患者人群中评估后,才能推荐用于患者。

局限性

  • 原文结论指出研究存在重要局限性,这些发现应视为初步结果,需重复验证并在其他患者人群中评估后,才能推荐用于患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Being born small for gestational age (SGA) is a leading cause of perinatal morbidity and mortality with no effective prevention or therapy. Maternal suboptimal nutrition and high stress levels have been associated with poor fetal growth and adverse pregnancy outcomes. OBJECTIVE: To investigate whether structured interventions based on a Mediterranean diet or mindfulness-based stress reduction (stress reduction) in high-risk pregnancies can reduce the percentage of newborns who were born SGA and other adverse pregnancy outcomes. DESIGN, SETTING, AND PARTICIPANTS: Parallel-group randomized clinical trial conducted at a university hospital in Barcelona, Spain, including 1221 individuals with singleton pregnancies (19-23 weeks' gestation) at high risk for SGA. Enrollment took place from February 1, 2017, to October 10, 2019, with follow-up until delivery (final follow-up on March 1, 2020). INTERVENTIONS: Participants in the Mediterranean diet group (n = 407) received 2 hours monthly of individual and group educational sessions and free provision of extra-virgin olive oil and walnuts. Individuals in the stress reduction group (n = 407) underwent an 8-week stress reduction program adapted for pregnancy, consisting of weekly 2.5-hour sessions and 1 full-day session. Individuals in the usual care group (n = 407) received pregnancy care per institutional protocols. MAIN OUTCOMES AND MEASURES: The primary end point was the percentage of newborns who were SGA at delivery, defined as birth weight below the 10th percentile. The secondary end point was a composite adverse perinatal outcome (at least 1 of the following: preterm birth, preeclampsia, perinatal mortality, severe SGA, neonatal acidosis, low Apgar score, or presence of any major neonatal morbidity). RESULTS: Among the 1221 randomized individuals (median [IQR] age, 37 [34-40] years), 1184 (97%) completed the trial (392 individuals assigned to the Mediterranean diet group, 391 to the stress reduction group, and 401 to the usual care group). SGA occurred in 88 newborns (21.9%) in the control group, 55 (14.0%) in the Mediterranean diet group (odds ratio [OR], 0.58 [95% CI, 0.40-0.84]; risk difference [RD], -7.9 [95% CI, -13.6 to -2.6]; P = .004), and 61 (15.6%) in the stress reduction group (OR, 0.66 [95% CI, 0.46-0.94]; RD, -6.3 [95% CI, -11.8 to -0.9]; P = .02). The composite adverse perinatal outcome occurred in 105 newborns (26.2%) in the control group, 73 (18.6%) in the Mediterranean diet group (OR, 0.64 [95% CI, 0.46-0.90]; RD, -7.6 [95% CI, -13.4 to -1.8]; P = .01), and 76 (19.5%) in the stress reduction group (OR, 0.68 [95% CI, 0.49-0.95]; RD, -6.8 [95% CI, -12.6 to -0.3]; P = .02). CONCLUSIONS AND RELEVANCE: In this randomized trial conducted at a single institution in Spain, treating pregnant individuals at high risk for SGA with a structured Mediterranean diet or with mindfulness-based stress reduction, compared with usual care, significantly reduced the percentage of newborns with birth weight below the 10th percentile. Due to important study limitations, these findings should be considered preliminary and require replication, as well as assessment in additional patient populations, before concluding that these treatments should be recommended to patients. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03166332.

来源:JAMA,查看原文。版权归原作者所有。

引用

  1. Crovetto F, Crispi F, Casas R, et al. Effects of Mediterranean Diet or Mindfulness-Based Stress Reduction on Prevention of Small-for-Gestational Age Birth Weights in Newborns Born to At-Risk Pregnant Individuals: The IMPACT BCN Randomized Clinical Trial. JAMA. 2021. PMID: 34874420. doi:10.1001/jama.2021.20178

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。